HALOZYME THERAPEUTICS, INC. - COM (HALO)

Q4 2022 Portfolio Holders as of 12/31/2022

Type / Class
Equity / COM
Number of holders
410
Total Shares
128M
Shares change
-2.08M
Total reported value, excl. options
$7.31B
Value change
-$109M
Put/Call ratio
0.31
Number of buys
184
Number of sells
-190
Price
$56.90
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.